Skip to content

Study · Non-randomized trial · 1990

2 results

[Correction of immunologic disorders in patients with burns].

Shkrob LO, Lukoianova TN, Vishnevskaia SM, Panova IuM, Kashin IuD

Khirurgiia1 Feb 1990

PMID2335880 (opens in a new tab)PepBankPUB-02335880
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In patients with burns, adding Thymalin to multimodality therapy contributed to rapid normalization of immunological parameters.

    In plain wordsIn patients with burns, adding Thymalin to multimodality therapy helped normalize immune measures rapidly.

    Peptide
    Thymalin
    Outcome
    Direction not reportedImmunological parameter normalization
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Addition of immunomodulating therapy with Thymalin, a thymus agent, to the multimodality therapy of burnt patients contributes to a rapid normalization of immunological parameters.
  2. 02HumanNon-randomized trialEfficacy outcome

    In burn patients with severely depressed T-system immunity and high drug sensitivity, maximal immune response occurred 7-10 days after an early Thymalin therapy course.

    In plain wordsIn burn patients with severely suppressed immunity and high drug sensitivity, the strongest response occurred 7-10 days after an early Thymalin treatment course.

    Peptide
    Thymalin
    Outcome
    Not applicableTiming of maximal immune response
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Measurements

    Time to most marked immune response after therapy course
    7 to 10 days
    Burn patients with severely depressed T-system immunity, early Thymalin course

    Source sentences

    Summary
    The most marked immune response was observed 7-10 days after a therapy course initiated in the early periods of burn disease in patients with severely depressed T-system immunity and a high sensitivity to the drug.
    1 context sentence
    Summary · context
    Addition of immunomodulating therapy with Thymalin, a thymus agent, to the multimodality therapy of burnt patients contributes to a rapid normalization of immunological parameters.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.